We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

TTAB Greenlights Boehringer's 'Breathless' Trademark

Law360, New York (November 28, 2017, 6:06 PM EST) -- The Trademark Trial and Appeal Board on Monday ruled that drugmaker Boehringer Ingelheim Pharmaceuticals Inc. can register “breathless” as a trademark for promoting awareness about a rare fatal lung disorder, overturning...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.